Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma Foods Intl FY Net Y1.99B Vs Net Y368.00M
Pharma Foods International Co. Ltd. (2929.TO) Japan Year Ended July 31 GROUP 2026 2025 Revenue Y63.22 bln Y65.26 bln Operating Profit Y2.63 bln Y2.37 bln Pretax Profit Y2.44 bln Y2.55 bln Net Profit Y1.99 bln Y368.00 mln Per share Earnings Y68.61…
Trump surgeon general nominee discloses tobacco, pharma investments
President Trump's surgeon general nominee reported investments in the tobacco company Philip Morris International as well as beverage companies Monster Beverage Corp, Coca Cola Co. and Pepsi Co., according to financial disclosures released…
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Company announcement – No. 47 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 10, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ:…
Hong Kong watchdog investigates Cloudbreak Pharma for 'rigged' IPO
Hong Kong's Securities and Futures Commission (SFC) has directed the stock exchange to suspend trading of US-based biotech firm Cloudbreak Pharma pending an investigation into its US$78 million initial public offering (IPO) last year. “The…
SFC orders biotech firm Cloudbreak Pharma to suspend trading
The Securities and Futures Commission has directed the stock exchange of Hong Kong to suspend all dealing in the shares of Cloudbreak Pharma (2592), effective at 9:00 am on Thursday. SCROLL TO CONTINUE WITH CONTENT The regulatory action was…
SFC orders biotech firm Cloudbreak Pharma to suspend trading over suspected IPO rigging
The Securities and Futures Commission has directed the stock exchange of Hong Kong to suspend all dealing in the shares of Cloudbreak Pharma (2592) over suspected IPO rigging, effective at 9:00 am on Thursday. SCROLL TO CONTINUE WITH CONTENT Under…
IHE: Large-Cap Pharma Cools After A Hot Summer (NYSEARCA:IHE)
I issue a hold rating on the iShares US Pharmaceuticals ETF due to fair valuation and mounting near-term headwinds. IHE's portfolio is highly concentrated, with 43% in JNJ and LLY and top 10 holdings totaling 76%. Technical trends have turned…
LSL PHARMA GROUP ANNOUNCES CFO TRANSITION
BOUCHERVILLE, QC, Sept. 10, 2026 /CNW/ -- LSL PHARMA GROUP INC. (TSXV: LSL) (the 'Corporation' or 'LSL Pharma'), a Canadian integrated pharmaceutical company, today announced that Luc Mainville will be leaving his position as Chief Financial…
BridgeBio Pharma Stock: Attruby Peak Sales Set To Rise (NASDAQ:BBIO)
BridgeBio Pharma has delivered multiple clinical and commercial successes, yet shares have repeatedly sold off after positive catalysts. Infigratinib's dwarfism trial outperformed the market leader, and Attruby continues to beat sales estimates…
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?
The Fidelity MSCI Health Care Index ETF (FHLC -0.42%) provides broad healthcare exposure at a fraction of the cost of the State Street SPDR S&P Pharmaceuticals ETF (XPH -1.51%), which targets a specific industry niche. Investors seeking healthcare…
HC Wainwright Reiterates 'Buy' Rating for BridgeBio Pharma (NASDAQ:BBIO)
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report)'s stock had its 'buy' rating reaffirmed by investment analysts at HC Wainwright in a research note issued on Thursday, Benzinga reports. They presently have a $120.00 target price on the stock. HC…
Why two promising heart drugs flopped and what's next
On this week's episode of “The Readout LOUD”: The pharma industry invested billions of dollars to develop drugs heralded as the next era in the treatment of heart disease — but why did they fail? And what does this mean for the…
VIT Chennai - The Hindu Biotech Conclave to throw spotlight on opportunities shaping the future of life sciences
The VIT Chennai–The Hindu Biotech Conclave 2026, to be held in Chennai today, will bring together leading experts, industry leaders and academicians for a one-day dialogue on the growing role of biotechnology in shaping the future. Conceived…
The Race for the Next Big Weight-Loss Drug Is On-and China Wants In
SHANGHAI—Chinese biotech companies, rapidly evolving from manufacturers of low-end generic drugs to serious competitors to American pharma giants, are training their sights on one of the most lucrative medicines: GLP-1s. Today Eli Lilly and…
What Mayawati's latest BSP shake-up signals
Mayawati's decision came a week after she removed Akash as the party's national convener and shortly after she asked Siddharth, a former Rajya Sabha MP, to retire from politics to protect his son-in-law's political future. BSP sources said Mayawati…
Receive a Daily briefing on Pharma Industry News
Get Started